We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.06%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$8.66B
AUM Growth
+$908M
Cap. Flow
+$609M
Cap. Flow %
7.04%
Top 10 Hldgs %
13.15%
Holding
1,050
New
339
Increased
147
Reduced
104
Closed
359

Top Buys

Rank Stock Value
1
WDAY icon
Workday
WDAY
+$130M
2
KSU
Kansas City Southern
KSU
+$79.4M
3
FTV icon
Fortive
FTV
+$74.8M
4
PAYC icon
Paycom
PAYC
+$74.3M
5
CTOS icon
Custom Truck One Source
CTOS
+$68.8M

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$113M
2
ADBE icon
Adobe
ADBE
+$90.8M
3
INTC icon
Intel
INTC
+$70.3M
4
VRT icon
Vertiv
VRT
+$59.9M
5
TJX icon
TJX Companies
TJX
+$53M

Sector Composition

Rank Sector Weight
1 Technology 22.2%
2 Healthcare 16.19%
3 Industrials 14.03%
4 Financials 13.86%
5 Consumer Discretionary 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COOLU
676
DELISTED
Corner Growth Acquisition Corp. Unit
COOLU
$259K ﹤0.01%
+25,648
New +$258K
SNCE
677
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$258K ﹤0.01%
+1,291
New +$262K
OBIO icon
678
Orchestra BioMed
OBIO
$256M
$255K ﹤0.01%
25,000
– –
EPWR
679
DELISTED
Empowerment & Inclusion Capital I Corp.
EPWR
$245K ﹤0.01%
25,000
– –
FLS icon
680
Flowserve
FLS
$10.2B
$238K ﹤0.01%
+5,907
New +$244K
GE icon
681
GE Aerospace
GE
$385B
$237K ﹤0.01%
+3,537
New +$236K
DBTX
682
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$233K ﹤0.01%
27,047
-19,653
-42% -$173K
SPRB
683
Spruce Biosciences
SPRB
$129M
$218K ﹤0.01%
+259
New +$276K
ARMK icon
684
Aramark
ARMK
$14.6B
$216K ﹤0.01%
+8,036
New +$221K
TJX icon
685
TJX Companies
TJX
$177B
$206K ﹤0.01%
3,054
-776,946
-100% -$53M
AGCO icon
686
AGCO
AGCO
$7.2B
$204K ﹤0.01%
1,565
-161,485
-99% -$22.7M
LOKM.U
687
DELISTED
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
$201K ﹤0.01%
20,000
-30,000
-60% -$301K
NEXI
688
DELISTED
NexImmune, Inc. Common Stock
NEXI
$186K ﹤0.01%
457
-2,543
-85% -$1.17M
APGN
689
DELISTED
Apexigen, Inc. Common Stock
APGN
$169K ﹤0.01%
17,000
– –
BTTX
690
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$143K ﹤0.01%
+14,400
New +$143K
VENAR
691
DELISTED
Venus Acquisition Corporation Rights
VENAR
$28K ﹤0.01%
+50,000
New +$20.8K
ACEL icon
692
Accel Entertainment
ACEL
$992M
– –
-68,814
Closed -$752K
ADI icon
693
Analog Devices
ADI
$191B
– –
-279,161
Closed -$43.3M
ADM icon
694
Archer Daniels Midland
ADM
$37.2B
– –
-512,813
Closed -$29.2M
ADMA icon
695
ADMA Biologics
ADMA
$2.19B
– –
-265,820
Closed -$468K
ADSK icon
696
Autodesk
ADSK
$52.3B
– –
-132,614
Closed -$36.8M
ADVM
697
DELISTED
Adverum Biotechnologies
ADVM
– –
-3,508
Closed -$346K
AGO icon
698
Assured Guaranty
AGO
$3.34B
– –
-206,882
Closed -$8.75M
AHCO icon
699
AdaptHealth
AHCO
$742M
– –
-628,786
Closed -$23.1M
ALGN icon
700
Align Technology
ALGN
$12.3B
– –
-41,574
Closed -$22.5M
26 27
28
29 30

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2021 Portfolio in Review

As of Q2 2021, Alyeska Investment Group held 1,050 positions worth $8.66B, up 12% from $7.75B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Alyeska Investment Group deployed $609M of net new capital in Q2 2021, opening 339 new positions and adding to 147 existing holdings. Its largest new stake was Workday: 542,446 shares worth $130M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Salesforce, an estimated $113M trimmed.

  • Alyeska Investment Group's largest Q2 2021 buy was Workday: 542,446 shares worth $130M.
  • Alyeska Investment Group added most to Paycom in Q2 2021, an estimated $74.3M increase.
  • Alyeska Investment Group's biggest Q2 2021 reduction was Salesforce, cutting an estimated $113M.
  • Alyeska Investment Group fully exited Paramount Global Class B in Q2 2021, selling an estimated $51.8M.
  • Alyeska Investment Group's ten largest holdings make up 13% of its $8.66B portfolio in Q2 2021.
  • Alyeska Investment Group opened 339 new positions and closed 359 in Q2 2021.
  • Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $8.66B.

Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.